LGR5

LGR5

LGR5 Overview

Molecule Name
Leucine-rich repeat-containing G-protein coupled receptor 5
Synonyms
LGR5, GPR49, GPR67, G-protein coupled receptor 49, G-protein coupled receptor 67, G-protein coupled receptor HG38, Leucine-rich repeat-containing G-protein coupled receptor 5
Drug Development Progress
Drugs in Clinical Trials2
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
FEX,G Protein-Coupled Receptor 49,GRP49,HG38,G-protein coupled receptor HG38,GPR49,GPR67,G-protein coupled receptor 49,Leucine-rich repeat-containing G-protein coupled receptor 5,LGR5,Leucine Rich Repeat Containing G Protein-Coupled Receptor 5,G-Protein Coupled Receptor 67,Orphan G Protein-Coupled Receptor HG38
Background
LGR5 (also known as GPR49) is a seven-transmembrane protein of the class A Rhodopsin-like family of GPCRs. LGR5 and LGR4 bind the R-spondins with high affinity and mediate the potentiation of Wnt/β-catenin signaling by enhancing Wnt-induced LRP6 phosphorylation. The LGR5/RSPO complex could promote Wnt signalling via the neutralization of two transmembrane E3 ligases, RNF43 and ZNRF3.

LGR5 Product List

Species
  • Human(3)
  • Cynomolgus(1)
  • Mouse(1)
Tag
  • Fc Tag(2)
  • His Tag(2)
  • His Tag & Avi Tag(1)
Host
  • HEK293(5)
Conjugate
  • Unconjugated(4)
  • Biotin-labeled(1)
Grade
  • RUO(5)
Low Endotoxin
  • Yes(1)
  • No(4)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&Price
LGR5
Cynomolgus LGR5 / GPR49 protein, His Tag
Cynomolgus
HEK293
SDS-PAGE
ELISA

$360.00

100ug
LGR5
Human LGR5 / GPR49 protein, Fc Tag
Human
HEK293
SDS-PAGE
ELISA

$380.00

100ug
LGR5
Human LGR5 / GPR49 Protein, His Tag, low endotoxin
Human
HEK293
SDS-PAGE
ELISASPR

$435.00

100ug
LGR5
Avitag
LG5-H82E4
Biotinylated Human LGR5 / GPR49 (22-561) Protein, His,Avitag™
Human
HEK293
SDS-PAGE
ELISA

$360.00

25ug
LGR5
Mouse LGR5 / GPR49 Protein, Fc Tag
Mouse
HEK293
SDS-PAGE
ELISA

$360.00

100ug
You Have Viewed 1-5 Of 5 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
PetosemtamabMCLA-158Phase 2 ClinicalMerus Nv
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms
Details
CNA-3103CNA-3103Phase 2 ClinicalCarina Biotech Pty Ltd
Colorectal Neoplasms
Details
Customer Reviews